Gianmarco Leone, Francesco Orlando, Peter Dutey-Magni, Osvaldas Vainauskas, Emily Grist, Yari Ciani, Sharanpreet Lall, Suparna Thakali, Anna Wingate, Daniel Wetterskog, Ashwin Sachdeva, Matthew R Sydes, Neil McPhail, Thiagarajan Sreenivasan, Joe M O'Sullivan, Noel W Clarke, Mahesh K B Parmar, Louise C Brown, Nicholas D James, Francesca Demichelis, Gerhardt Attard
{"title":"Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.","authors":"Gianmarco Leone, Francesco Orlando, Peter Dutey-Magni, Osvaldas Vainauskas, Emily Grist, Yari Ciani, Sharanpreet Lall, Suparna Thakali, Anna Wingate, Daniel Wetterskog, Ashwin Sachdeva, Matthew R Sydes, Neil McPhail, Thiagarajan Sreenivasan, Joe M O'Sullivan, Noel W Clarke, Mahesh K B Parmar, Louise C Brown, Nicholas D James, Francesca Demichelis, Gerhardt Attard","doi":"10.1001/jamaoncol.2024.7051","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":48661,"journal":{"name":"Jama Oncology","volume":" ","pages":""},"PeriodicalIF":28.4000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869088/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jama Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamaoncol.2024.7051","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
期刊介绍:
At JAMA Oncology, our primary goal is to contribute to the advancement of oncology research and enhance patient care. As a leading journal in the field, we strive to publish influential original research, opinions, and reviews that push the boundaries of oncology science.
Our mission is to serve as the definitive resource for scientists, clinicians, and trainees in oncology globally. Through our innovative and timely scientific and educational content, we aim to provide a comprehensive understanding of cancer pathogenesis and the latest treatment advancements to our readers.
We are dedicated to effectively disseminating the findings of significant clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our ultimate objective is to facilitate the translation of new knowledge into tangible clinical benefits for individuals living with and surviving cancer.